E-MTAB-2383 - RNA-seq of mouse breast tumor cell line 4T1

Released on 5 March 2014, last updated on 7 March 2014
Mus musculus
Samples (3)
Protocols (5)
Background: the transcription of tumor mutations from DNA into RNA has implications for biology, epigenetics and clinical practice. It is not clear if mutations are in general transcribed and, if so, at what proportion to the wild-type allele. Here, we examined the correlation between DNA mutation allele frequency and RNA mutation allele frequency. Methods: we sequenced the exome and transcriptome of tumor cell lines with large copy number variations, identified heterozygous single nucleotide mutations and absolute DNA copy number, and determined the corresponding DNA and RNA mutation allele fraction. Results: we found that 99% of the DNA mutations in expressed genes are expressed as RNA. Moreover, we found a high correlation between the DNA and RNA mutation allele frequency. Exceptions are mutations that cause premature termination codons and therefore activate nonsense-mediated decay. Beyond this, we did not find evidence of any wide-scale mechanism, such as allele-specific epigenetic silencing, preferentially promoting mutated or wild-type alleles. Conclusion: taken together, our data strongly suggest that genes are equally transcribed from all alleles, mutated and wild-type, and thus transcribed in proportion to their DNA allele frequency.
Experiment types
RNA-seq of coding RNA, co-expression, disease state design, replicate design
Mutated tumor alleles are expressed according to their DNA frequency.
Exp. designProtocolsVariablesProcessedSeq. reads
Investigation descriptionE-MTAB-2383.idf.txt
Sample and data relationshipE-MTAB-2383.sdrf.txt